Article info

other Versions

PDF
Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma

Authors

  1. Correspondence to Dr Maria Rosaria Raspollini, Histopathology and Molecular Diagnostics, Universitary Hospital Careggi, Florence 30134, Italy; mariarosaria.raspollini{at}unifi.it
View Full Text

Citation

Raspollini MR, Montagnani I, Montironi R, et al
Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma

Publication history

  • Received November 24, 2017
  • Revised December 18, 2017
  • Accepted December 20, 2017
  • First published January 9, 2018.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.